HUGE THINGS TO COME $$$$$$$$$$$$$$
Amarantus BioScience (AMBS) To Be Biotech Stock Of 2013_Acquisition Discussions Already Underway Projects Biotech News Stock Review
Amarantus BioScience (AMBS) To Be Biotech Stock Of 2013_Acquisition Discussions Already Underway Projects Biotech News Stock Review.
Adam believes that he has found the golden egg, AMBS. He may very well be correct, what I'm hearing is that buyout discussions are already happening between this small biotech and a big pharmaceutical. I'm working my sources but things are pretty hush hush with NDA's having to be signed. Adam may be correct and AMBS could certainly become the biotech stock of the year.
About Biotech News Stock Review
Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.
Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.
If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.
Posted by Sierra World Equity Review at 1:05 AM
